Root Financial Partners
SABS icon

Root Financial Partners’s SAB Biotherapeutics SABS Stock Holding History

Root Financial Partners’s Portfolio SABS Stock Details SABS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10 Buy
+3
New +$11 ﹤0.01% 3806

Other funds holding SABS

IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
First PREMIER Bank
First PREMIER Bank Sioux Falls, South Dakota $621M AUM 13.03% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Root Financial Partners's SABS Position: Q3 2026 in Review

Root Financial Partners opened a new position in SAB Biotherapeutics (SABS) in Q3 2026: 3 shares worth $10. The stake represents ﹤0.01% of the portfolio and ranks #3806 among its holdings.

5 funds tracked by Wall St. Rank hold SABS as of Q3 2026.

  • Root Financial Partners held 3 shares of SAB Biotherapeutics worth $10 as of Q3 2026.
  • SAB Biotherapeutics was a new Root Financial Partners position in Q3 2026.
  • SAB Biotherapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3806 holding.
  • 5 funds tracked by Wall St. Rank held SAB Biotherapeutics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.